Early response as predictor of final remission in elderly depressed patients

International Journal of Geriatric Psychiatry

Volumn 24, Issue 11, 2009, Pages 1299-1303

  Kok, Rob M ^a   Van Baarsen, Carlijn ^b   Nolen, Willem A ^c   Heeren, Thea J ^d  

^a PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^b Knowledge Centre of Psychiatry in the Elderly   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Symfora Group Centers of Mental Health Care   (Netherlands)

Author keywords

Early improvement; Elderly; Final response; Major depression; Prediction

Indexed keywords

NORTRIPTYLINE; VENLAFAXINE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; ELDERLY CARE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REMISSION; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED; NORTRIPTYLINE; REMISSION INDUCTION; ROC CURVE; TREATMENT OUTCOME;

EID: 70350726337     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2261     Document Type: Article

References (9)

1. Gelenberg AJ, Chesen CL. 2000. How fast are antidepressants? J Clin Psychiatry 61: 712-721.
2. Kieser M, Szegedi A. 2005. Predicting stable treatment response in patients with major depression treated with Hypericum extract WS 5570/5572. Pharmacopsychiatry 38: 194-200. (Pubitemid 41414864)
3. Kok RM, NolenWA, Heeren TJ. 2007. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients. A randomised, double-blind, controlled trial. Int J Geriatr Psychiatry 22: 1247-1254.
4. Koran LM, Hamilton SH, Hertzman M, Meyers BS, Halaris AS, Tollefson GD, et al. 1995. Predicting response to fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 15: 421-427. (Pubitemid 26005592)
5. Mulsant BH, Houck PR, Gildengers AG, Andreescu C, Dew MA, Pollock BG, et al. 2006. What is the optimal duration of a short-term antidepressant trail when treating geriatric depression? J Clin Psychopharmacol 26: 113-120.
6. Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, Worthington JJ, RosenbaumJ, et al. 2000. Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry 157: 1423-1428. (Pubitemid 30677134)
7. Quitkin FM, Petkova E, McGrath PJ, Taylor B, Beasley C, Steward J, et al. 2003. When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry 160: 734-740.
8. Sackeim HA, Roose SP, Burt T. 2005. Optimal length of antidepressant trails in late-life depression. J Clin Psychopharmacol 25 (suppl 1): S34-S37. (Pubitemid 41060245)
9. Szegedi A, Müller M, Anghelescu I, Klawe C, Kohnen R, Benckert O. 2003. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry 64: 413-420. (Pubitemid 36547285)